BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 22814509)

  • 1. Towards an HIV cure: a global scientific strategy.
    ; Deeks SG; Autran B; Berkhout B; Benkirane M; Cairns S; Chomont N; Chun TW; Churchill M; Di Mascio M; Katlama C; Lafeuillade A; Landay A; Lederman M; Lewin SR; Maldarelli F; Margolis D; Markowitz M; Martinez-Picado J; Mullins JI; Mellors J; Moreno S; O'Doherty U; Palmer S; Penicaud MC; Peterlin M; Poli G; Routy JP; Rouzioux C; Silvestri G; Stevenson M; Telenti A; Van Lint C; Verdin E; Woolfrey A; Zaia J; Barré-Sinoussi F
    Nat Rev Immunol; 2012 Jul; 12(8):607-14. PubMed ID: 22814509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The challenge of finding a cure for HIV infection.
    Richman DD; Margolis DM; Delaney M; Greene WC; Hazuda D; Pomerantz RJ
    Science; 2009 Mar; 323(5919):1304-7. PubMed ID: 19265012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International AIDS Society global scientific strategy: towards an HIV cure 2016.
    Deeks SG; Lewin SR; Ross AL; Ananworanich J; Benkirane M; Cannon P; Chomont N; Douek D; Lifson JD; Lo YR; Kuritzkes D; Margolis D; Mellors J; Persaud D; Tucker JD; Barre-Sinoussi F; ; Alter G; Auerbach J; Autran B; Barouch DH; Behrens G; Cavazzana M; Chen Z; Cohen ÉA; Corbelli GM; Eholié S; Eyal N; Fidler S; Garcia L; Grossman C; Henderson G; Henrich TJ; Jefferys R; Kiem HP; McCune J; Moodley K; Newman PA; Nijhuis M; Nsubuga MS; Ott M; Palmer S; Richman D; Saez-Cirion A; Sharp M; Siliciano J; Silvestri G; Singh J; Spire B; Taylor J; Tolstrup M; Valente S; van Lunzen J; Walensky R; Wilson I; Zack J
    Nat Med; 2016 Aug; 22(8):839-50. PubMed ID: 27400264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on Human Immunodeficiency Virus (HIV) Cure: HIV Persistence in Tissue.
    Boritz EA; Douek DC
    J Infect Dis; 2017 Mar; 215(suppl_3):S128-S133. PubMed ID: 28520970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV Persistence During Therapy--Third International Workshop. 4-7 December 2007, St Maarten, West Indies.
    Alcamí P
    IDrugs; 2008 Feb; 11(2):87-9. PubMed ID: 18240089
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular mechanisms of HIV-1 proviral latency.
    Bisgrove D; Lewinski M; Bushman F; Verdin E
    Expert Rev Anti Infect Ther; 2005 Oct; 3(5):805-14. PubMed ID: 16207172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle-Based Immunoengineered Approaches for Combating HIV.
    Bowen A; Sweeney EE; Fernandes R
    Front Immunol; 2020; 11():789. PubMed ID: 32425949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress towards an HIV cure: update from the 2014 International AIDS Society Symposium.
    Anderson JL; Fromentin R; Corbelli GM; Østergaard L; Ross AL
    AIDS Res Hum Retroviruses; 2015 Jan; 31(1):36-44. PubMed ID: 25257573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1st International Workshop on HIV Persistence during Therapy. St. Martin, December 10-12, 2003.
    Tossing G
    Eur J Med Res; 2004 Feb; 9(2):83-6. PubMed ID: 15090294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Insights into HIV-1 Persistence in Sanctuary Sites During Antiretroviral Therapy.
    Poveda E; Tabernilla A
    AIDS Rev; 2016; 18(1):55. PubMed ID: 27028272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication of HIV in infected patients: some potential approaches.
    Yang QE
    Med Sci Monit; 2004 Jul; 10(7):RA155-65. PubMed ID: 15232518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals.
    Trono D; Van Lint C; Rouzioux C; Verdin E; Barré-Sinoussi F; Chun TW; Chomont N
    Science; 2010 Jul; 329(5988):174-80. PubMed ID: 20616270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can HIV infection be eradicated through use of potent antiviral agents?
    Josefsson L; Dahl V; Palmer S
    Curr Opin Infect Dis; 2010 Dec; 23(6):628-32. PubMed ID: 20847693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Block-And-Lock: New Horizons for a Cure for HIV-1.
    Moranguinho I; Valente ST
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33334019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Between a shock and a hard place: challenges and developments in HIV latency reversal.
    Zerbato JM; Purves HV; Lewin SR; Rasmussen TA
    Curr Opin Virol; 2019 Oct; 38():1-9. PubMed ID: 31048093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Models of Human Immunodeficiency Virus Persistence and Cure Strategies.
    Nixon CC; Mavigner M; Silvestri G; Garcia JV
    J Infect Dis; 2017 Mar; 215(suppl_3):S142-S151. PubMed ID: 28520967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reservoirs of HIV replication after successful combined antiretroviral treatment.
    Belmonte L; Baré P; de Bracco MM; Ruibal-Ares BH
    Curr Med Chem; 2003 Feb; 10(4):303-12. PubMed ID: 12570703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of Current Strategies Towards the Elimination of Latent HIV-1 and Subsequent HIV-1 Cure.
    Maina EK; Adan AA; Mureithi H; Muriuki J; Lwembe RM
    Curr HIV Res; 2021; 19(1):14-26. PubMed ID: 32819259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV/AIDS research. Tissue says blood is misleading, confusing HIV cure efforts.
    Cohen J
    Science; 2011 Dec; 334(6063):1614. PubMed ID: 22194536
    [No Abstract]   [Full Text] [Related]  

  • 20. Latency reversal and viral clearance to cure HIV-1.
    Margolis DM; Garcia JV; Hazuda DJ; Haynes BF
    Science; 2016 Jul; 353(6297):aaf6517. PubMed ID: 27463679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.